-
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the U.S. and will have a list price of $1,400. But its impact will hinge on how easily people can access it, experts say. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSSTrending
Policy & Advocacy
-
A win for healthcare workers and patients: The CDC returns HICPAC’s draft recommendations on infection control
-
Senate hearing highlights Long Covid crisis — but not Covid-19 prevention — while advocacy groups bring their demands to DC
-
Social media users ask, “Where is Mandy?” as CDC director stays out of spotlight during Covid surge
-
Long Covid advocates face challenges, potential discrimination with billboard campaigns
-
What’s happening this week, January 9
-
Q&A: Eric Topol on Long Covid clinical trials, RECOVER funding, what he’s looking forward to in 2024
Science
Covid-19
-
Some U.S. COVID-19 data are down amid “pause” to federal health communications
-
Long COVID is a smoldering threat to wildland firefighters
-
National COVID-19 trends, January 21
-
National COVID-19 trends, January 14
-
“Stand Together,” an excerpt from The Covid Safety Handbook
-
National COVID-19 trends, January 7
Health
-
Nursing aides plagued by PTSD after ‘nightmare’ COVID conditions, with little help
-
For people with severe Long COVID, medical care is out of reach
-
Introducing Long COVID Essentials, a new resource series
-
Outdoor dining fades as pandemic persists — making public spaces even less accessible
-
Grappling with Long COVID as an elite athlete
-
Climate change is worsening symptoms of Long Covid and POTS. Here’s how people are navigating it.
-
The U.K.’s plan for ME has failed us. Members of parliament must step up.
-
Work until you disappear: Long COVID ensnared me in an exploitative health system
-
We must free Long COVID and the people living with it from the mind-body trap
-
Research ethics boards need urgent training on Long COVID and myalgic encephalomyelitis